Craniopharyngioma clinical trials

Explore recruiting craniopharyngioma clinical trials.

Recruiting craniopharyngioma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Craniopharyngioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neoadjuvant and postoperative treatment with dabrafenib and trametinib for papillary craniopharyngioma

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

PNOC029_Tovorafenib for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults

Netherlands, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity secondary to craniopharyngioma in children aged 12 to 17 years

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Craniopharyngioma trials by city

Craniopharyngioma in Toronto Craniopharyngioma in Vancouver Craniopharyngioma in Montreal Craniopharyngioma in Calgary Craniopharyngioma in Edmonton Craniopharyngioma in Ottawa Craniopharyngioma in Winnipeg Craniopharyngioma in Quebec City Craniopharyngioma in Hamilton Craniopharyngioma in Kitchener Craniopharyngioma in London Craniopharyngioma in Halifax Craniopharyngioma in New York Craniopharyngioma in Los Angeles Craniopharyngioma in Chicago Craniopharyngioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease